The observed pooled relapse rate post-TNF-α inhibitor withdrawal in our study provides important quantitative data that complement existing information regarding relapse rates after discontinuation of other DMARD therapies in RA patients. The gene discussed is TNF; the disease is rheumatoid arthritis.